4d
Zacks Investment Research on MSNSage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?A month has gone by since the last earnings report for Sage Therapeutics, Inc. (SAGE). Shares have added about 7.4% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
Now is perhaps not the time to open our wallets any wider, the state’s top Republican said in response to Gov. Maura Healey’s $62 billion fiscal 2026 budget proposal. According to Senate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results